EWTX — Edgewise Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Edgewise Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	129	281	352	318	470
Prepaid Expenses
Total Current Assets	130	284	357	327	475
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.516	0.912	9.85	12.7	11.1
Other Long Term Assets
Total Assets	131	285	367	340	487
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	4.34	10.5	16.6	16.8	23.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.34	10.8	20.4	21.2	27.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	127	274	347	319	459
Total Liabilities & Shareholders' Equity	131	285	367	340	487
Total Common Shares Outstanding